[e-drug] (Updated info) Dying from Lack of Treatment

[David Veazey <david_veazey@newyork.msf.org>]

E-drug: (Updated info) Dying from Lack of Treatment
-------------------------------------------------------------------------

Final updated information on Thurday's panel discussion in
New York:

M�decins Sans Fronti�res/Doctors Without Borders (MSF) invites
you to a panel discussion:

"Dying from Lack of Treatment: The International AIDS Crisis"

7 pm, Thursday, June 21
Proshansky Auditorium, The Graduate Center, City University of
New York, 365 Fifth Avenue at 34th Street, Manhattan

Reception at 6:30pm

8,000 people die every day from AIDS around the world even
though effective treatments exist. On June 25, 2001, the United
Nations is holding its first ever special session on AIDS. Treatment
with antiretrovirals for the world's poor is barely up for discussion.
When will the international community stop discussing whether or
not to treat people with AIDS in poor countries and start seriously
planning how?

Speakers:
Chris Ouma, M.D., Action Aid Kenya, treats people with AIDS in
the slums of Nairobi. Dr. Ouma has been an outspoken critic of
international trade agreements that have kept antiretrovirals out of
the reach of his patients.

Onanong Bunjumnong, MSF-Thailand, leads MSF's Access To
Essential Medicines Campaign in Thailand, where MSF has been
treating people with AIDS for 6 years. She works closely with local
NGOs and the Thai Network of People Living with HIV/AIDS.

Konstantin Lezhentsev, M.D., MSF-Ukraine, was instrumental in
setting up Ukraine's first HIV treatment program focused on
mothers and their children. In addition to his clinical work, he
advocates for affordable treatments with the government and works
closely with the All-Ukrainian National Network of People Living
with HIV/AIDS.

Rose Mougnutou, M.D. MSF-Cameroon, has been treating people
with AIDS with antiretrovirals at the University Hospital of Yaounde
for over 3 years. She currently works in an MSF pilot project
providing antiretroviral therapy.

Moderator: Anne-Valerie Kaninda, M.D., MSF-USA Medical Adviser

This program has been arranged in conjunction with Continuing
Education and Public Programs at The Graduate Center, City
University of New York. 

David Veazey
MSF-USA
david_veazey@newyork.msf.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.